Value Investing Research & Market Analysis

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

316.23 -47.53 (-13.07%)
Delayed Quote Updated: 1:30 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Natera Analysts Increase Their Forecasts Following Upbeat Results ↗
 
Via Benzinga
News headline image
Stocks Edge Higher, Dollar Hits 1-Year Peak, Bitcoin Soars To $93,000: What's Driving Markets Wednesday? ↗
Wall Street rebounds on inflation report, with consumer discretionary and real estate sectors leading. Senator John Thune elected majority leader. U.S. dollar hits 1-year high. 
Via Benzinga
Topics Economy
News headline image
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Natera? ↗
 
Via Benzinga
News headline image
Exploring NASDAQ:NTRA's high growth characteristics. ↗
NATERA INC (NASDAQ:NTRA) is a candidate for high growth investors. Here's why. 
Via Chartmill
News headline image
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Natera Reports Third Quarter 2024 Financial Results
From Natera, Inc.
Via Business Wire
News headline image
Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday? ↗
Wall Street saw the first surge in risk aversion after Donald Trump's election victory last week, as concerns grew over potential tariffs and trade policy shifts spurred by the incoming... 
Via Benzinga
Topics Government World Trade
News headline image
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
From Natera, Inc.
Via Business Wire
News headline image
Evaluating Natera: Insights From 10 Financial Analysts ↗
 
Via Benzinga
News headline image
3 Under-the-Radar Healthcare Companies
While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains. 
Via MarketBeat
News headline image
Natera to Participate in Upcoming Investor Conferences
From Natera, Inc.
Via Business Wire
News headline image
Smaller Cap Biotechs Are In Season: How Are We Doing? ↗
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
News headline image
Natera to Report its Third Quarter 2024 Results on November 12, 2024
From Natera, Inc.
Via Business Wire
News headline image
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). ↗
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). 
Via Chartmill
News headline image
Analyst Scoreboard: 9 Ratings For Natera ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
News headline image
Natera to Present New Renasight Data at ASN Kidney Week 2024
From Natera, Inc.
Via Business Wire
News headline image
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas ↗
It is Fall clean up time. Sell lagging and sagging companies. 
Via Talk Markets
News headline image
Peering Into Natera's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Natera Through Analyst Insights ↗
 
Via Benzinga
News headline image
A Biotech Breakout Will Be Led By Small Caps ↗
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
News headline image
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
From Natera, Inc.
Via Business Wire
News headline image
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗
A Relative Strength Rating upgrade for Tempus AI shows improving technical performance. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO
From Natera, Inc.
Via Business Wire
News headline image
First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
From Natera, Inc.
Via Business Wire
News headline image
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
From Natera, Inc.
Via Business Wire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The recent stock market dip provided some discounts. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.